ConductScience.org, home

Paper6524928

Drug targeting by drug entrapment into ultrafine compartments as carriers.

Speiser P. Appl Biochem Biotechnol, 1984. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Drug targeting by drug entrapment into ultrafine compartments as carriers. Papers, record 6524928. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6524928

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Drug targeting by drug entrapment into ultrafine compartments as carriers.
PubMed
Journal
Appl Biochem Biotechnol
PubMed
Year
1984
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.08
iCite
Revised in PubMed
2026-10-11
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Speiser PP

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CapsulesMajor topic
Pharmaceutical PreparationsMajor topic
Animals
Biological Transport, Active
Colloids
Dactinomycin
Influenza Vaccines
Neoplasms, Experimental
Subcellular Fractions

Source PubMed

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1598,513Nanocapsules: a new type of lysosomotropic carrier.FEBS Lett1977https://conductscience.org/library/papers/598513PubMed
24,433,467Morphological observations on the cellular and subcellular destination of intravenously administered liposomes.Br J Exp Pathol1974https://conductscience.org/library/papers/4433467PubMed
37,120,064Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles.J Pharm Sci1982https://conductscience.org/library/papers/7120064PubMed
41,220,973Liposomes containing 3H-actinomycin D. differential tissue distribution by varying the mode of drug incorporation.Eur J Cancer (1965)1975https://conductscience.org/library/papers/1220973PubMed
5329,659Persorption of particles: physiology and pharmacology.Adv Pharmacol Chemother1977https://conductscience.org/library/papers/329659PubMed
64,434,987Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected into rats. Possible therapeutic applications.Eur J Biochem1974https://conductscience.org/library/papers/4434987PubMed
77,120,063Toxicity of polyalkylcyanoacrylate nanoparticles I: Free nanoparticles.J Pharm Sci1982https://conductscience.org/library/papers/7120063PubMed
81,248,871New adjuvants on a polymethylmethacrylate base.Infect Immun1976https://conductscience.org/library/papers/1248871PubMed
94,371,790Analytical fractionation of homogenates from cultured rat embryo fibroblasts.J Cell Biol1974https://conductscience.org/library/papers/4371790PubMed
104,507,516Chemotherapy through lysosomes with a DNA-daunorubicin complex.Nat New Biol1972https://conductscience.org/library/papers/4507516PubMed
11164,280The specific cytotoxic effects of daunomycin conjugated to antitumor antibodies.Cancer Res1975https://conductscience.org/library/papers/164280PubMed
12512,896Distribution and elimination of poly(methyl-2-14C-methacrylate) nanoparticle radioactivity after injection in rats and mice.J Pharm Sci1979https://conductscience.org/library/papers/512896PubMed
13993,993In vitro studies of poly(methyl methacrylate) adjuvants.J Pharm Sci1976https://conductscience.org/library/papers/993993PubMed
144,606,365Commentary. Lysosomotropic agents.Biochem Pharmacol1974https://conductscience.org/library/papers/4606365PubMed
1555,519A morphologic and biochemical study of the fate of antibody-bearing liposomes.Lab Invest1976https://conductscience.org/library/papers/55519PubMed
1615,355Nanoencapsulated fluorescence indicator molecules measuring pH and pO2 down to submicroscopical regions in the basis of the optode-principle.Z Naturforsch C Biosci1977https://conductscience.org/library/papers/15355PubMed
1711,946,312On the metabolic pathway of methylmethacrylate.FEBS Lett1969https://conductscience.org/library/papers/11946312PubMed

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
6,395,808Artificial cells in medicine and biotechnology.Appl Biochem Biotechnol1984https://conductscience.org/library/papers/6395808

Source PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6524928

GET https://conductscience.org/api/papers/v1/6524928/authors